INMUNE BIO INC. Sale of Stock, Consideration Received Per Transaction
INMUNE BIO INC. (INMB) reported Sale of Stock, Consideration Received Per Transaction of $18.70 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-04.
Discontinued › Notes › Equity
us-gaap:SaleOfStockConsiderationReceivedPerTransaction · last filed 2021-03-04
- INMUNE BIO INC. sale of stock, consideration received per transaction for the quarter ending 2020-12-31 was $0.00.
- INMUNE BIO INC. sale of stock, consideration received per transaction for the quarter ending 2020-09-30 was $0.00.
- INMUNE BIO INC. sale of stock, consideration received per transaction for the quarter ending 2020-06-30 was $0.00.
- INMUNE BIO INC. sale of stock, consideration received per transaction for the quarter ending 2020-03-31 was $18.70M.
- INMUNE BIO INC. sale of stock, consideration received per transaction for fiscal 2020 was $18.70M.
| Period end | Sale of Stock, Consideration Received Per Transaction 2 month | Sale of Stock, Consideration Received Per Transaction 3 month | Sale of Stock, Consideration Received Per Transaction 6 month | Sale of Stock, Consideration Received Per Transaction 9 month | Sale of Stock, Consideration Received Per Transaction 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $0.00 derived: sum of 2 quarters · filed 2021-03-04 | $0.00 derived: sum of 3 quarters · filed 2021-03-04 | $18.70M 10-K · filed 2021-03-04 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $18.70M 10-Q · filed 2020-11-05 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $18.70M 10-Q · filed 2020-08-05 | |||
| 2020-03-31 | $18.70M 10-Q · filed 2020-05-14 | ||||
| 2019-05-31 | $4.73M 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |